Skip to main content
Clinical Trials/NL-OMON51879
NL-OMON51879
Not yet recruiting
Not Applicable

Detection of sepsis at the intensive care unit with non-invasive transcutaneous blood gas monitoring. - COSMOS

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Erasmus MC, Universitair Medisch Centrum Rotterdam
Enrollment
50
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • Sepsis group:
  • Sepsis classified as 2 SIRS criteria and suspected infection
  • Signs of hypoperfusion, requiring noradrenaline administration of at least
  • 0\.5 µg/min/kg
  • Written informed consent.
  • Control group:
  • No fulfillment of 2 SIRS criteria, nor suspected infection
  • No signs of hypoperfusion, noradrenaline administration of less than or equal
  • to 0\.5 µg/min/kg
  • Written informed consent.

Exclusion Criteria

  • Sepsis group:
  • No sepsis
  • Skin condition contraindicating transcutaneous blood gas measurements.
  • Absence of written informed consent.
  • Control group:
  • Sepsis classified as 2 SIRS criteria and suspected infection
  • Skin condition contraindicating transcutaneous blood gas measurements.
  • Absence of written informed consent.

Outcomes

Primary Outcomes

Not specified

Similar Trials